By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Salix Pharmaceuticals, Ltd. 

1700 Perimeter Park Drive

Morrisville  North Carolina  27560  U.S.A.
Phone: 919-862-1000 Fax: 919-862-1095



Company News
Salix (SLXP) Release: FDA Grants RUCONEST (C1 Esterase Inhibitor [Recombinant]) Twelve-Year Reference Product Exclusivity 10/8/2015 7:21:01 AM
BioDelivery Sciences International (BDSI) Strengthens Sales Force Leadership With Hiring Of Scott Plesha, Former Salix (SLXP) Head Of Sales 8/12/2015 6:21:34 AM
RedHill Biopharma Ltd. (RDHL) Provides Update On RHB-106 Program Partnered With Salix (SLXP) 7/27/2015 7:25:43 AM
Salix (SLXP) Announces FDA Approval of Xifaxan 550 mg For The Treatment Of IBS-D (Irritable Bowel Syndrome With Diarrhea) 5/28/2015 6:15:37 AM
Atlantic Healthcare Plc Announces The Appointment Of Lorin K. Johnson, PhD To The Board Of Directors Following The Sale Of Salix (SLXP) 4/13/2015 9:44:48 AM
Valeant (VRX) Sacks 258 Salix (SLXP) Employees; Confirms "Limited Presence" in North Carolina 4/3/2015 5:49:46 AM
With A Few Short Words, Salix (SLXP) As A Company Disappears 4/2/2015 7:40:06 AM
Salix (SLXP) Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes And Merger Event Relating To Its 1.5% Convertible Senior Notes Due 2019 4/2/2015 6:52:55 AM
Redemption Of All Of Salix (SLXP)'s Outstanding 6.00% Senior Notes Due 2021 4/1/2015 9:35:08 AM
Valeant (VRX) Completes Acquisition Of Salix (SLXP) 4/1/2015 8:38:33 AM